AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

StageZero Life Sciences Ltd.

$0 +$0.00 (+100.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.01
Year Range
$0$0.01
Market Cap
123.53K
AVG Volume
7
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
02M4M6M8M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q32.99M
23 Q23.05M
23 Q13.25M
22 Q43.8M
22 Q34.62M
22 Q24.51M
22 Q13.91M
21 Q45.07M
21 Q36.16M
21 Q26.94M
Net Income (USD) · TTM
-30M-20M-10M010M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q3-20.56M
23 Q2-18.31M
23 Q1-18.42M
22 Q4-14.72M
22 Q3126.65K
22 Q2-3.52M
22 Q11.31M
21 Q4-7.48M
21 Q3-4.7M
21 Q2-7.12M
Operating Income (USD) · TTM
-15M-10M-5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q3-4.58M
23 Q2-5.27M
23 Q1-6.46M
22 Q4-7.81M
22 Q3-9.17M
22 Q2-10.21M
22 Q1-10.54M
21 Q4-9.61M
21 Q3-7.23M
21 Q2-5.31M
EBITDA (USD) · TTM
-15M-10M-5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q3-11.91M
23 Q2-10.98M
23 Q1-11.83M
22 Q4-10.7M
22 Q3-3.45M
22 Q2-5.66M
22 Q1-143.91K
21 Q4-6.88M
21 Q3-5.51M
21 Q2-4M
Cash Flows (USD) · TTM
-15M-10M-5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q3-823.52K
23 Q2-942.41K
23 Q1-1.51M
22 Q4-3.53M
22 Q3-5.73M
22 Q2-8.22M
22 Q1-10.25M
21 Q4-9.1M
21 Q3-6.35M
21 Q2-5.08M
EPS (USD) · TTM
-0.2-0.100.121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q3-0.19
23 Q2-0.17
23 Q1-0.17
22 Q4-0.13
22 Q30
22 Q2-0.04
22 Q10.01
21 Q4-0.11
21 Q3-0.11
21 Q2-0.18
Expenses (USD) · TTM
02.5M5M7.5M10MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q34.51M
23 Q24.96M
23 Q15.81M
22 Q46.98M
22 Q38.46M
22 Q29.44M
22 Q19.91M
21 Q49.15M
21 Q38.1M
21 Q26.77M
Shares Outstanding (USD) · TTM
-800K-600K-400K-200K0Buybacks (Repurchases)Stock-Based Compensation21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
SZLSF Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q3-629.92K
23 Q2-368.83K
23 Q1-138.16K
22 Q4-238.51K
22 Q3-101.53K
22 Q2-318.04K
22 Q1-495.28K
21 Q4-390.94K
21 Q3-165.67K
21 Q2-451.51K
PE Ratio
050100150200med 40.57Oct 20Nov 20Jul 22Aug 22Dec 22Feb 23Mar 23
SZLSF PE Ratio by quarter
PeriodPE Ratio
Mar 2359.6
Mar 2363.8
Mar 2360.82
Mar 2364.41
Feb 2358.07
Feb 2343.86
Feb 2340.57
Feb 2338.4
Jan 2339.04
Jan 2338.32
Jan 2338.32
Jan 2333.85
Dec 2233.85
Sep 224.34
Sep 224.34
Sep 224.95
Sep 224.95
Aug 225.26
Aug 224.66
Aug 225.75
Aug 225.38
Jul 224.48
Jul 224.34
Jul 224.34
Jul 224.34
Jul 224.59
Dec 20117.51
Dec 20116.32
Dec 20123.45
Dec 20130.27
Nov 20125.52
Nov 20118.7
Nov 20141.84
Nov 20134.13
Oct 20125.82
Oct 20151.93
Oct 20156.09
Oct 20157.57
Oct 20142.44
Free Cash Flow Yield
-200%-150%-100%-50%0%med -15.45%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SZLSF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-78.82%
Sep 26-78.82%
Aug 26-78.82%
Aug 26-78.82%
Aug 26-78.82%
Aug 26-78.82%
Jul 26-78.82%
Jul 26-78.82%
Jul 26-78.82%
Jul 26-78.82%
Jul 26-15.45%
Jun 26-15.45%
Jun 26-15.45%
Jun 26-15.45%
Jun 26-15.45%
May 26-15.45%
May 26-15.45%
May 26-15.45%
May 26-15.45%
May 26-15.45%
Apr 26-15.45%
Apr 26-15.45%
Apr 26-15.45%
Apr 26-15.45%
Mar 26-15.45%
Mar 26-157.63%
Mar 26-157.63%
Mar 26-157.63%
Feb 26-157.63%
Feb 26-157.63%
Feb 26-157.63%
Feb 26-157.63%
Jan 26-157.63%
Jan 26-157.63%
Jan 26-157.63%
Jan 26-157.63%
Jan 26-157.63%
Dec 25-157.63%
Dec 25-157.63%
Dec 25-15.45%
Dec 25-15.45%
Nov 25-15.45%
Nov 25-15.45%
Nov 25-15.45%
Nov 25-15.45%
Oct 25-15.45%
Oct 25-15.45%
Oct 25-15.45%
Oct 25-15.45%
Oct 25-15.45%
Sep 25-15.45%
Sep 25-6.74%
Sep 25-6.74%
Sep 25-6.74%
Aug 25-6.74%
Aug 25-3.67%
Aug 25-3.67%
Aug 25-4.15%
Aug 25-3.37%
Jul 25-3.46%
Jul 25-3.46%
Jul 25-3.46%
Jul 25-3.46%
Jun 25-3.3%
Jun 25-2.75%
Jun 25-3.28%
Jun 25-26.27%
May 25-26.27%
May 25-26.27%
May 25-26.27%
May 25-26.27%
May 25-26.27%
Apr 25-26.27%
Apr 25-4.15%
Apr 25-26.27%
Apr 25-26.27%
Mar 25-26.27%
Mar 25-7.88%
Mar 25-37.53%
Mar 25-2.91%
Feb 25-3.94%
Feb 25-3.94%
Feb 25-46.36%
Feb 25-46.36%
Jan 25-46.36%
Jan 25-46.36%
Jan 25-49.26%
Jan 25-3.33%
Jan 25-1.16%
Dec 24-50.88%
Dec 24-1.78%
Dec 24-50.88%
Dec 24-3.54%
Nov 24-50.88%
Nov 24-6.51%
Nov 24-3.34%
Nov 24-3.34%
Nov 24-1.02%
Oct 24-0.81%
Oct 24-0.81%
Price to Sales
0246med 0.29Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SZLSF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.06
Sep 260.06
Aug 260.06
Aug 260.06
Aug 260.06
Aug 260.06
Jul 260.06
Jul 260.06
Jul 260.06
Jul 260.06
Jul 260.29
Jun 260.29
Jun 260.29
Jun 260.29
Jun 260.29
May 260.29
May 260.29
May 260.29
May 260.29
May 260.29
Apr 260.29
Apr 260.29
Apr 260.29
Apr 260.29
Mar 260.29
Mar 260.03
Mar 260.03
Mar 260.03
Feb 260.03
Feb 260.03
Feb 260.03
Feb 260.03
Jan 260.03
Jan 260.03
Jan 260.03
Jan 260.03
Jan 260.03
Dec 250.03
Dec 250.03
Dec 250.29
Dec 250.29
Nov 250.29
Nov 250.29
Nov 250.29
Nov 250.29
Oct 250.29
Oct 250.29
Oct 250.29
Oct 250.29
Oct 250.29
Sep 250.29
Sep 250.67
Sep 250.67
Sep 250.67
Aug 250.67
Aug 251.23
Aug 251.23
Aug 251.09
Aug 251.34
Jul 251.31
Jul 251.31
Jul 251.31
Jul 251.31
Jun 251.37
Jun 251.64
Jun 251.38
Jun 250.17
May 250.17
May 250.17
May 250.17
May 250.17
May 250.17
Apr 250.17
Apr 251.09
Apr 250.17
Apr 250.17
Mar 250.17
Mar 250.57
Mar 250.12
Mar 251.55
Feb 251.15
Feb 251.15
Feb 250.1
Feb 250.1
Jan 250.1
Jan 250.1
Jan 250.09
Jan 251.36
Jan 253.89
Dec 240.08
Dec 242.31
Dec 240.08
Dec 241.16
Nov 240.08
Nov 240.63
Nov 241.23
Nov 241.23
Nov 244.01
Oct 245.05
Oct 245.05
Price to Book
010203040med 3.18Oct 15Oct 21Jan 22May 22Aug 22Dec 22Mar 23
SZLSF Price to Book by quarter
PeriodPrice to Book
Mar 235.23
Mar 235.59
Mar 235.33
Mar 235.65
Feb 235.09
Feb 233.85
Feb 233.56
Feb 233.37
Jan 233.42
Jan 233.36
Jan 233.36
Jan 232.97
Dec 222.97
Dec 223.49
Dec 224.66
Dec 225.26
Dec 224.64
Nov 225.02
Nov 225.21
Nov 225.21
Nov 225.01
Oct 225.01
Oct 225.01
Oct 225.01
Oct 225.01
Sep 225.01
Sep 221.97
Sep 221.97
Sep 222.24
Sep 222.24
Aug 222.39
Aug 222.11
Aug 222.61
Aug 222.44
Jul 222.03
Jul 221.97
Jul 221.97
Jul 221.97
Jul 222.08
Jun 222.08
Jun 222.17
Jun 222.41
Jun 222.21
May 222.49
May 222.33
May 222.58
May 222.83
Apr 222.45
Apr 222.45
Apr 222.83
Apr 223.13
Apr 224.6
Mar 223.34
Mar 223.23
Mar 223.09
Mar 223.5
Feb 223.53
Feb 224.08
Feb 224.44
Feb 224.3
Jan 224.11
Jan 224.22
Jan 225.3
Jan 225.52
Dec 215.08
Dec 2128.92
Dec 2128.11
Dec 2132.15
Dec 2129.4
Nov 2132.31
Nov 2126.82
Nov 2132.31
Nov 2132.8
Oct 2136.19
Oct 2139.1
Oct 2138.77
Oct 2136.67
Oct 2137.8
Dec 150.06
Dec 150.12
Dec 150.07
Dec 150.13
Nov 150.05
Nov 150.09
Nov 150.45
Nov 150.9
Oct 150.9
Oct 150.9
Oct 150.88
Oct 150.98
Oct 151
Sep 150.63
Sep 150.59
Sep 150.65
Sep 150.56
Aug 150.64
Aug 150.54
Aug 150.66
Aug 150.66
Jul 150.61
StageZero Life Sciences Ltd.
SZLSF
Stockpicker

Video analysis: SZLSF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.